SCHEMBL6568622

SCHEMBL6568622

O=C(Cc1c(Br)cc(Br)c(O)c1Br)N1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 3/20 0.49
MAPT P10636 4/20 0.40
KMT2A Q03164 3/20 0.40
RAB9A P51151 4/20 0.40
GAA P10253 3/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 3/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ECE2 P0DPD6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568533 0.98 NPC1 (0.46) NPC1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL6659568 0.70 TTR (0.39) TSHRALDH1A1
SCHEMBL4384593 0.70 KMT2A (0.51) NPC1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL11317215 0.67 NPC1 (0.57) NPC1SMN1; SMN2HPGDKMT2ARAB9A
SCHEMBL6565612 0.67 HPGD (0.53) NPC1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL23887302 0.66 HPGD (0.48) NPC1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL14969283 0.66 KMT2A (0.53) NPC1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL31335307 0.66 HPGD (1.00) NPC1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL11324605 0.65 NPC1 (0.54) NPC1SMN1; SMN2HPGDKMT2ARAB9A
SCHEMBL23565681 0.65 HPGD (0.67) NPC1SMN1; SMN2HPGDMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed